Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Antiretroviral-Based Prevention by Enhancing PrEP Adherence in MSM

NCT01632397 is registered in ClinicalTrials.gov with Fenway Community Health as lead sponsor.

NCT NCT01632397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01632397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Antiretroviral-Based Prevention by Enhancing PrEP Adherence in MSM
Lead sponsor
Fenway Community Health
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2011
Completion date
February 28, 2014
Enrollment
103 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

medication adherence